Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

Eshe Nelson
Author: Eshe Nelson

Written by

Eshe Nelson

in

Appointments and Executive Changes, Company Reports, Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Ozempic (Drug), Regulation and Deregulation of Industry, Stocks and Bonds
←‘Fleetwood Mac’ at 50: A Marvel of Serendipity and Perfectionism
Cannonball with Wesley Morris: Beyoncé Isn’t Giving Up on America→

More posts

  • ‘Avengers: Secret Wars’: Noah Jupe Joins Upcoming Marvel Studios Movie

  • Tokyo Film Festival To Open & Close With ‘Sukiyaki’ & ‘Colony’; ‘Godzilla Minus Zero’ Set As Centerpiece Film

  • Superb England crush Ireland with record ODI chase

  • Under Trump, the IRS’ audit revenue falls in predictable and damaging ways

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube